OSAKA METROPOLITAN UNIVERSITY IMAGE: CATIONIC LIPID-INTRODUCED PH-RESPONSIVE POLYSACCHARIDE-MODIFIED LIPOSOMES TO ACHIEVE EFFICIENT ANTIGEN DELIVERY AND HIGHLY ACTIVATION OF ANTIGEN PRESENTING CELLS TOWARDS INDUCTION OF ANTIGEN-SPECIFIC IMMUNE RESPONSES. CREDIT: EIJI YUBA, OSAKA METROPOLITAN UNIVERSITY Cancer immunotherapies, such as immune checkpoint inhibition therapy, have been attracting attention in recent years as new methods for treating cancer. However,...
Tag: <span>Cellular Immunity</span>
Post
BA.4 and BA.5 Subvariants Are More Evasive of Antibodies, but Not of Cellular Immunity
Monica Gandhi, MD, MPH July 12, 2022 The picture around the BA.4 and BA.5 subvariants of Omicron has been really confusing in that the pair is driving up cases but global COVID-19 deaths remain at their lowest level since the beginning of the pandemic. I wanted to explain what is happening with these subvariants in that the...